UK markets open in 1 hour 36 minutes

Viking Therapeutics, Inc. (1VT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
47.36+0.36 (+0.77%)
At close: 03:32PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
76,901
63,806
54,234
44,981
31,931
-
Selling general and administrative
37,462
37,021
16,121
10,701
10,731
-
Total operating expenses
114,363
100,827
70,355
55,682
42,662
-
Operating income or loss
-114,363
-100,827
-70,355
-55,682
-42,662
-
Interest expense
-
-
-
-
-
0
Total other income/expenses net
-
-
-42
7
40
4
Income before tax
-93,720
-85,895
-68,867
-54,990
-39,495
-
Income from continuing operations
-93,720
-85,895
-68,867
-54,990
-39,495
-
Net income
-93,720
-85,895
-68,867
-54,990
-39,495
-
Net income available to common shareholders
-93,720
-85,895
-68,867
-54,990
-39,495
-
Basic EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Diluted EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Basic average shares
88,507
94,347
76,834
77,198
72,597
-
Diluted average shares
88,507
94,347
76,834
77,198
72,597
-